Cargando…

Old versus New: Why Do We Need New Antiepileptic Drugs?

Achieving complete seizure remission without adverse events is the goal of epilepsy treatment. Recently, many new antiepileptic drugs (AEDs) have been developed. Even though the efficacy of new AEDs is not stronger than that of old AEDs, there are advantages in using new AEDs. They have unique or di...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Sang Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Epilepsy Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295052/
https://www.ncbi.nlm.nih.gov/pubmed/25625087
_version_ 1782352782857076736
author Lee, Sang Kun
author_facet Lee, Sang Kun
author_sort Lee, Sang Kun
collection PubMed
description Achieving complete seizure remission without adverse events is the goal of epilepsy treatment. Recently, many new antiepileptic drugs (AEDs) have been developed. Even though the efficacy of new AEDs is not stronger than that of old AEDs, there are advantages in using new AEDs. They have unique or different mechanisms of action that enable the creation of possible synergistic combinations. They usually exhibit fewer or no pharmacokinetic drug interactions. Furthermore, the response to AEDs varies individually. A similar efficacy does not imply a similar response from all patients. Many new AEDs have fewer adverse events, including induction of congenital malformations. Other concerns about the long-term effects of established AEDs, such as bone health and development of atherosclerosis, may be alleviated by the use of new AEDs. New AEDs are needed to achieve better care of patients with epilepsy.
format Online
Article
Text
id pubmed-4295052
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Epilepsy Society
record_format MEDLINE/PubMed
spelling pubmed-42950522015-01-26 Old versus New: Why Do We Need New Antiepileptic Drugs? Lee, Sang Kun J Epilepsy Res Review Achieving complete seizure remission without adverse events is the goal of epilepsy treatment. Recently, many new antiepileptic drugs (AEDs) have been developed. Even though the efficacy of new AEDs is not stronger than that of old AEDs, there are advantages in using new AEDs. They have unique or different mechanisms of action that enable the creation of possible synergistic combinations. They usually exhibit fewer or no pharmacokinetic drug interactions. Furthermore, the response to AEDs varies individually. A similar efficacy does not imply a similar response from all patients. Many new AEDs have fewer adverse events, including induction of congenital malformations. Other concerns about the long-term effects of established AEDs, such as bone health and development of atherosclerosis, may be alleviated by the use of new AEDs. New AEDs are needed to achieve better care of patients with epilepsy. Korean Epilepsy Society 2014-12-31 /pmc/articles/PMC4295052/ /pubmed/25625087 Text en Copyright © 2014 Korean Epilepsy Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Lee, Sang Kun
Old versus New: Why Do We Need New Antiepileptic Drugs?
title Old versus New: Why Do We Need New Antiepileptic Drugs?
title_full Old versus New: Why Do We Need New Antiepileptic Drugs?
title_fullStr Old versus New: Why Do We Need New Antiepileptic Drugs?
title_full_unstemmed Old versus New: Why Do We Need New Antiepileptic Drugs?
title_short Old versus New: Why Do We Need New Antiepileptic Drugs?
title_sort old versus new: why do we need new antiepileptic drugs?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295052/
https://www.ncbi.nlm.nih.gov/pubmed/25625087
work_keys_str_mv AT leesangkun oldversusnewwhydoweneednewantiepilepticdrugs